RECURSION PHARMACEUTICALS IN shareholders Q2 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 157 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.96 and the average weighting 1.1%.

RECURSION PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
ADVISORY RESEARCH INC 135,683$1,013,5520.13%
Delphia (USA) Inc. 10,212$76,2840.12%
GoalFusion Wealth Management, LLC 20,000$149,4000.11%
Corton Capital Inc. 19,801$147,9130.07%
Nikko Asset Management Americas, Inc. 837,400$6,247,0040.07%
TITLEIST ASSET MANAGEMENT, LLC 35,750$267,0530.05%
Virtus ETF Advisers LLC 11,028$82,3790.05%
Accel Wealth Management 10,330$77,1650.04%
FOX RUN MANAGEMENT, L.L.C. 18,917$141,3100.04%
Dynamic Technology Lab Private Ltd 40,629$3030.04%
DARK FOREST CAPITAL MANAGEMENT LP 45,294$338,3460.03%
Manchester Capital Management LLC 26,880$200,7940.03%
PROFUND ADVISORS LLC 59,614$445,3170.02%
Wedmont Private Capital 16,943$201,6220.02%
Pentwater Capital Management LP 365,000$2,726,5500.02%
PRELUDE CAPITAL MANAGEMENT, LLC 36,386$271,8030.02%
Clarius Group, LLC 28,601$213,6490.02%
Virtu Financial LLC 27,205$2030.02%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 174,435$1,3030.01%
CREDIT SUISSE AG/ 1,699,891$12,698,1850.01%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q2 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.